Venous thromboembolism (VTE) therapeutics market set to hit $3.7 billion by 2025
1 August 2016 | By GlobalData
Growth will be driven by the uptake of novel oral anticoagulants, which represent important advances over warfarin, a cheap and established anticoagulant, says new report...